Secondary immunodeficiency in lymphoproliferative malignancies.
Secondary immunodeficiencies occur as a consequence of various diseases, including hematological malignancies, and the use of pharmacological therapies, such as immunosuppressive, anti‐inflammatory, and biological drugs. Infections are the main cause of morbidity and mortality in multiple myeloma (M...
Main Authors: | Friman, V, Winqvist, O, Blimark, C, Langerbeins, P, Chapel, H, Dhalla, F |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2016
|
Similar Items
-
Challenges in the role of gammaglobulin replacement therapy and vaccination strategies for hematological malignancy
by: Sánchez-Ramón, S, et al.
Published: (2018) -
Dysregulation of FBW7 in malignant lymphoproliferative disorders
by: Xin Wan, et al.
Published: (2022-11-01) -
Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme.
by: Dhalla, F, et al.
Published: (2011) -
Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme
by: Dhalla, F, et al.
Published: (2011) -
Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation
by: Vasil Toskov, et al.
Published: (2023-09-01)